Novel mutations in ADSL for Adenylosuccinate Lyase Deficiency identified by the combination of Trio-WES and constantly updated guidelines

Abstract Whole-exome sequencing (WES), one of the next-generation sequencing (NGS), has become a powerful tool to identify exonic variants. Investigating causality of the sequence variants in human disease becomes an important part in NGS for the research and clinical applications. Recently, importa...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Xiao Mao, Kai Li, Beisha Tang, Yang Luo, Dongxue Ding, Yuwen Zhao, Chunrong Wang, Xiaoting Zhou, Zhenhua Liu, Yuan Zhang, Puzhi Wang, Qian Xu, Qiying Sun, Kun Xia, Xinxiang Yan, Hong Jiang, Shen Lu, Jifeng Guo
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
R
Q
Acceso en línea:https://doaj.org/article/2c9660dc723f4dc5a26d3e4f3edf3d8e
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:2c9660dc723f4dc5a26d3e4f3edf3d8e
record_format dspace
spelling oai:doaj.org-article:2c9660dc723f4dc5a26d3e4f3edf3d8e2021-12-02T12:32:33ZNovel mutations in ADSL for Adenylosuccinate Lyase Deficiency identified by the combination of Trio-WES and constantly updated guidelines10.1038/s41598-017-01637-z2045-2322https://doaj.org/article/2c9660dc723f4dc5a26d3e4f3edf3d8e2017-05-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-01637-zhttps://doaj.org/toc/2045-2322Abstract Whole-exome sequencing (WES), one of the next-generation sequencing (NGS), has become a powerful tool to identify exonic variants. Investigating causality of the sequence variants in human disease becomes an important part in NGS for the research and clinical applications. Recently, important guidelines on them have been published and will keep on updating. In our study, two Chinese families, with the clinical diagnosis of “Epilepsy”, which presented with seizures, psychomotor retardation, hypotonia and etc. features, were sequenced by Trio-WES (including the proband and the unaffected parents), and a standard interpretation of the identified variants was performed referring to the recently updated guidelines. Finally, we identified three novel mutations (c.71 C > T, p.P24L; c.1387-1389delGAG, p.E463-; c.134 G > A, p.W45*; NM_000026) in ADSL in the two Chinese families, and confirmed them as the causal variants to the disease-Adenylosuccinate Lyase Deficiency. Previous reported specific therapy was also introduced to the patients after our refined molecular diagnosis, however, the effect was very limited success. In summary, our study demonstrated the power and advantages of WES in exploring the etiology of human disease. Using the constantly updated guidelines to conduct the WES study and to interpret the sequence variants are a necessary strategy to make the molecular diagnosis and to guide the individualized treatment of human disease.Xiao MaoKai LiBeisha TangYang LuoDongxue DingYuwen ZhaoChunrong WangXiaoting ZhouZhenhua LiuYuan ZhangPuzhi WangQian XuQiying SunKun XiaXinxiang YanHong JiangShen LuJifeng GuoNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-7 (2017)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Xiao Mao
Kai Li
Beisha Tang
Yang Luo
Dongxue Ding
Yuwen Zhao
Chunrong Wang
Xiaoting Zhou
Zhenhua Liu
Yuan Zhang
Puzhi Wang
Qian Xu
Qiying Sun
Kun Xia
Xinxiang Yan
Hong Jiang
Shen Lu
Jifeng Guo
Novel mutations in ADSL for Adenylosuccinate Lyase Deficiency identified by the combination of Trio-WES and constantly updated guidelines
description Abstract Whole-exome sequencing (WES), one of the next-generation sequencing (NGS), has become a powerful tool to identify exonic variants. Investigating causality of the sequence variants in human disease becomes an important part in NGS for the research and clinical applications. Recently, important guidelines on them have been published and will keep on updating. In our study, two Chinese families, with the clinical diagnosis of “Epilepsy”, which presented with seizures, psychomotor retardation, hypotonia and etc. features, were sequenced by Trio-WES (including the proband and the unaffected parents), and a standard interpretation of the identified variants was performed referring to the recently updated guidelines. Finally, we identified three novel mutations (c.71 C > T, p.P24L; c.1387-1389delGAG, p.E463-; c.134 G > A, p.W45*; NM_000026) in ADSL in the two Chinese families, and confirmed them as the causal variants to the disease-Adenylosuccinate Lyase Deficiency. Previous reported specific therapy was also introduced to the patients after our refined molecular diagnosis, however, the effect was very limited success. In summary, our study demonstrated the power and advantages of WES in exploring the etiology of human disease. Using the constantly updated guidelines to conduct the WES study and to interpret the sequence variants are a necessary strategy to make the molecular diagnosis and to guide the individualized treatment of human disease.
format article
author Xiao Mao
Kai Li
Beisha Tang
Yang Luo
Dongxue Ding
Yuwen Zhao
Chunrong Wang
Xiaoting Zhou
Zhenhua Liu
Yuan Zhang
Puzhi Wang
Qian Xu
Qiying Sun
Kun Xia
Xinxiang Yan
Hong Jiang
Shen Lu
Jifeng Guo
author_facet Xiao Mao
Kai Li
Beisha Tang
Yang Luo
Dongxue Ding
Yuwen Zhao
Chunrong Wang
Xiaoting Zhou
Zhenhua Liu
Yuan Zhang
Puzhi Wang
Qian Xu
Qiying Sun
Kun Xia
Xinxiang Yan
Hong Jiang
Shen Lu
Jifeng Guo
author_sort Xiao Mao
title Novel mutations in ADSL for Adenylosuccinate Lyase Deficiency identified by the combination of Trio-WES and constantly updated guidelines
title_short Novel mutations in ADSL for Adenylosuccinate Lyase Deficiency identified by the combination of Trio-WES and constantly updated guidelines
title_full Novel mutations in ADSL for Adenylosuccinate Lyase Deficiency identified by the combination of Trio-WES and constantly updated guidelines
title_fullStr Novel mutations in ADSL for Adenylosuccinate Lyase Deficiency identified by the combination of Trio-WES and constantly updated guidelines
title_full_unstemmed Novel mutations in ADSL for Adenylosuccinate Lyase Deficiency identified by the combination of Trio-WES and constantly updated guidelines
title_sort novel mutations in adsl for adenylosuccinate lyase deficiency identified by the combination of trio-wes and constantly updated guidelines
publisher Nature Portfolio
publishDate 2017
url https://doaj.org/article/2c9660dc723f4dc5a26d3e4f3edf3d8e
work_keys_str_mv AT xiaomao novelmutationsinadslforadenylosuccinatelyasedeficiencyidentifiedbythecombinationoftriowesandconstantlyupdatedguidelines
AT kaili novelmutationsinadslforadenylosuccinatelyasedeficiencyidentifiedbythecombinationoftriowesandconstantlyupdatedguidelines
AT beishatang novelmutationsinadslforadenylosuccinatelyasedeficiencyidentifiedbythecombinationoftriowesandconstantlyupdatedguidelines
AT yangluo novelmutationsinadslforadenylosuccinatelyasedeficiencyidentifiedbythecombinationoftriowesandconstantlyupdatedguidelines
AT dongxueding novelmutationsinadslforadenylosuccinatelyasedeficiencyidentifiedbythecombinationoftriowesandconstantlyupdatedguidelines
AT yuwenzhao novelmutationsinadslforadenylosuccinatelyasedeficiencyidentifiedbythecombinationoftriowesandconstantlyupdatedguidelines
AT chunrongwang novelmutationsinadslforadenylosuccinatelyasedeficiencyidentifiedbythecombinationoftriowesandconstantlyupdatedguidelines
AT xiaotingzhou novelmutationsinadslforadenylosuccinatelyasedeficiencyidentifiedbythecombinationoftriowesandconstantlyupdatedguidelines
AT zhenhualiu novelmutationsinadslforadenylosuccinatelyasedeficiencyidentifiedbythecombinationoftriowesandconstantlyupdatedguidelines
AT yuanzhang novelmutationsinadslforadenylosuccinatelyasedeficiencyidentifiedbythecombinationoftriowesandconstantlyupdatedguidelines
AT puzhiwang novelmutationsinadslforadenylosuccinatelyasedeficiencyidentifiedbythecombinationoftriowesandconstantlyupdatedguidelines
AT qianxu novelmutationsinadslforadenylosuccinatelyasedeficiencyidentifiedbythecombinationoftriowesandconstantlyupdatedguidelines
AT qiyingsun novelmutationsinadslforadenylosuccinatelyasedeficiencyidentifiedbythecombinationoftriowesandconstantlyupdatedguidelines
AT kunxia novelmutationsinadslforadenylosuccinatelyasedeficiencyidentifiedbythecombinationoftriowesandconstantlyupdatedguidelines
AT xinxiangyan novelmutationsinadslforadenylosuccinatelyasedeficiencyidentifiedbythecombinationoftriowesandconstantlyupdatedguidelines
AT hongjiang novelmutationsinadslforadenylosuccinatelyasedeficiencyidentifiedbythecombinationoftriowesandconstantlyupdatedguidelines
AT shenlu novelmutationsinadslforadenylosuccinatelyasedeficiencyidentifiedbythecombinationoftriowesandconstantlyupdatedguidelines
AT jifengguo novelmutationsinadslforadenylosuccinatelyasedeficiencyidentifiedbythecombinationoftriowesandconstantlyupdatedguidelines
_version_ 1718394027705892864